On Feb. 1, Alphabet (NASDAQ:GOOG, NASDAQ:GOOGL) announced that its board approved a stock split that would see shareholders receive 20 shares of GOOG stock for every share currently held. Alphabet’s shares jumped on the news.  Source: turtix / Shutterstock.com While there have been several high-profile stock splits in recent years, it is hard to know
0 Comments
Alphabet’s (NASDAQ:GOOG,NASDAQ:GOOGL) fourth-quarter (Q4) results showed that the company’s advertising and cloud businesses are quite healthy and growing very rapidly. Those trends should continue for the foreseeable future, pushing GOOG stock significantly higher. Source: Castleski / Shutterstock.com Meanwhile, the stock should also be boosted by the difficulties that a number of previous strong tech names
0 Comments
Jim Cramer Scott Mlyn | CNBC CNBC’s Jim Cramer said Tuesday the stock market may have “another couple days of this uncertainty,” until it becomes clear whether Russia will invade Ukraine or whether Moscow will stop with recognizing the independence of Luhansk and Donetsk, two breakaway regions there. “The market needs to get a little
0 Comments
When it comes to low-risk investing, annuities have traditionally been considered a good option. Generally associated with a steady stream of income, they can provide security for those looking to grow their savings and protect against market volatility. But it’s important to understand that annuity purchasers have options at the end of their term. A
0 Comments
If you’re in the market for a diversified, tech-centered investment, Vinco Ventures (NASDAQ:BBIG) stock may seem like a deal, but we should look deeper. Source: shutterstock.com/Postmodern Studio There’s no denying that BBIG stock is affordable, but whether it’s actually a good value is a different matter entirely. One thing that’s interesting about this stock is that some
0 Comments
Long before the Covid-19 pandemic, I touted Moderna (NASDAQ:MRNA) as the next wave in biotech. After its Covid-19 vaccine showed effectiveness, I called MRNA stock “the stock of the decade.” Then I bought some shares. After calling them fully valued in October,  I sold, booking fat profits. Source: diy13 / Shutterstock But even before my warning,
0 Comments
During the initial onset of the novel coronavirus, most large-cap businesses struggled, and Costco Wholesale (NASDAQ:COST) was no exception. Along with the major market indexes, COST stock lost value quickly. Source: ilzesgimene / Shutterstock.com Soon afterward, though, many defensive stocks staged a swift comeback. This showed how a company Costco can remain rock-solid during times of
0 Comments
Canadian cannabis company Sundial Growers (NASDAQ:SNDL) has been a disappointment to investors for much of its time as a publicly traded company. SNDL stock crashed in 2019 shortly after going public, as the company’s initial go-to-market strategy failed. Source: Postmodern Studio / Shutterstock.com Reddit traders found Sundial in early 2021, with shares spiking 725% to
0 Comments
Tracey Ryniec, Zacks value stock strategist, discusses how to add a little growth to your value stock search. Southwest Airlines: http://www.zacks.com/stock/quote/LUV?cid=CS-YOUTUBE-FT-VID Follow us on StockTwits: http://stocktwits.com/ZacksResearch Follow us on Twitter: https://twitter.com/ZacksResearch Like us on Facebook: https://www.facebook.com/ZacksInvestmentResearch
0 Comments
A credit score is a number that helps lenders evaluate a person’s credit report and estimate their credit risk. The most common credit score is the FICO score. A person’s FICO score is provided to lenders by the three major credit reporting agencies—Experian, TransUnion, and Equifax—to help lenders evaluate the risks of extending credit or
0 Comments
It’s last call at the Covid-19 vaccine party and shareholders of Novavax (NASDAQ:NVAX) stock should be headed for the coat check. Source: rarrarorro / Shutterstock.com Novavax’s share price is down 41% year-to-date, bringing its six-month decline to 65%. The prospects of the biopharmaceutical company bringing a vaccine against Covid-19 to market in the U.S. grow
0 Comments
Investors may almost forgive Novavax (NASDAQ:NVAX) for seeking approval for its coronavirus vaccine late. Traders are happy that NVAX stock rose alongside that of Moderna (NASDAQ:MRNA), Pfizer (NYSE:PFE), and BioNTech (NASDAQ:BNTX) in 2020 through 2021 Source: Vladimka production / Shutterstock.com This year, shares of those companies slumped. After Novavax gets approval from health regulators worldwide
0 Comments
Earnings season hasn’t been half bad: 77% of the reports have topped expectations on revenues and earnings, according to FactSet’s S&P 500 Earnings Insight. And yet tech stocks, in particular, have taken some beatings! Metaverse stocks are no exception. Source: Vit-Mar/Shutterstock This week’s earnings from Matterport (NASDAQ:MTTR) and Roblox (NYSE:RBLX) triggered double-digit declines in each
0 Comments